Coronavirus vaccine development is ahead of schedule, US official says

“From the time we had the available sequence [of the virus], we had hoped to be in clinical trials within two to three months,” Fauci said. “I’m happy to report to you this afternoon that we are on time at least, and maybe even a little better.”
Boston-based biotech company Moderna sent the first batch of its vaccine to the NIAID on Monday for study. Part of the White House’s $2.5 billion supplemental budget request includes more than $1 billion to spend on vaccine development. Using the additional funding, the institute expects to start human trials on about 25 volunteers by the end of April.
Worthy News reports from a biblical worldview with a commitment to accuracy, transparency, and editorial independence. Learn more about About Worthy News, our Editorial Standards, AI Use Policy, Ownership of Worthy News, News Tips and Corrections, and Worthy News Staff.
💡 Did you know? One of the best ways you can support Worthy News is by simply leaving a comment and sharing this article.
📢 Social media algorithms push content further when there’s more engagement — so every 👍 like, 💬 comment, and 🔄 share helps more people discover the truth. 🙌
